Advertisement
PerkinElmer
PerkinElmer

The Scientist

» hearing, microbiology and disease/medicine

Most Recent

image: Down and Dirty

Down and Dirty

By | September 1, 2012

Diverse plant communities create a disease-fighting "soil genotype."

3 Comments

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: Soil Harbors Antibiotic Resistance

Soil Harbors Antibiotic Resistance

By | August 30, 2012

Identical resistance genes in soil and clinical bacteria hint at dangerous genetic arms trade that is aggravating the antibiotic-resistance crisis.

4 Comments

image: Resisting TB

Resisting TB

By | August 30, 2012

A study finds that drug-resistant tuberculosis is more prevalent than current estimates suggest.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Boston to Test Bioterror Sensors

Boston to Test Bioterror Sensors

By | August 29, 2012

Federal officials will release harmless bacteria into subway tunnels beneath the Northeastern city to test new sensors designed to detect biological agents.

8 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Advertisement

Popular Now

  1. When Does a Smart Mouse Become Human?
  2. Most Earth-like Planet Found
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. AAAAA Is for Arrested Translation
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist